HC Wainwright & Co. Maintains Buy on Ikena Oncology, Lowers Price Target to $4

Benzinga · 05/29 10:36
HC Wainwright & Co. analyst Andres Maldonado maintains Ikena Oncology (NASDAQ:IKNA) with a Buy and lowers the price target from $11 to $4.